A Study to Measure the Expression of the HER2‐HER3 Dimer in Tumor and Blood (Exosomes) Samples From Patients With HER2 Positive Breast Cancer Receiving HER2 Targeted Therapies. This evidence concerns the gene ERBB2 and breast cancer.